[1]
E. Matos Pires and C. Moura, “Immune Response in Melanoma: A Basis to Understand the Role of Immunotherapy with Immune Checkpoint Inhibitors”, SPDV, vol. 76, no. 1, pp. 47-52, Apr. 2018.